Showing results (561-570 of 1,361) with videos related to
Sort By:
Pageof 137
The Journal of Clinical Investigation|September 1, 1977
Anabolic actions of reduced and S-carbamidomethylated human growth hormone and its plasmin digest in manS B Heymsfield, R A Bethel, E C Hall, et al.Brain Injury|December 19, 2022
Pediatric acquired brain injury resources for educators: a multi-year scan of Canadian-relevant internet resourcesLauren Saly, Sara A Marshall, Kylie D Mallory, et al.The Journal of Biological Chemistry|February 9, 2007
Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activityDexing Fang, David Hawke, Yanhua Zheng, et al.Nature Ecology & Evolution|April 22, 2022
Eukaryogenesis and oxygen in Earth historyDaniel B Mills, Richard A Boyle, Stuart J Daines, et al.Nature Communications|April 5, 2018
Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancersDaniel J McGrail, Lorenzo Federico, Yongsheng Li, et al.Journal of the National Cancer Institute|November 13, 2008
Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cellsShuangxing Yu, Mandi M Murph, Yiling Lu, et al.Cancer Research|October 5, 2001
Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicin-induced cell cycle arrest at the G(2)/M checkpointU Aytac, F X Claret, L Ho, et al.Geobiology|March 17, 2020
On the co-evolution of surface oxygen levels and animalsDevon B Cole, Daniel B Mills, Douglas H Erwin, et al.The Breast Journal|February 9, 2016
Identifying Factors and Techniques to Decrease the Positive Margin Rate in Partial Mastectomies: Have We Missed the Mark?Sara B Edwards, I Michael Leitman, Aaron J Wengrofsky, et al.Molecular Oncology|November 7, 2012
EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: inhibition by resveratrolKang Jin Jeong, Kyung Hwa Cho, Nattapon Panupinthu, et al.Pageof 137